Parambir S. Dulai

Statistics

Publications

112

Citations

6.4K

H-Index

Active since

2011

Affiliations

University of California San Diego(Current)

Western University

Icahn School of Medicine at Mount Sinai

Dartmouth–Hitchcock Medical Center

Northwestern University

Parambir S. Dulai is an author at University of California San Diego specializing in inflammatory bowel disease, gastrointestinal inflammation, and gastroenterology.

ORCID

Publications per year

2011–2025

112

Publications

112

Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease

Rohit Loomba, Victor Seguritan, Weizhong Li et al. · Cell Metabolism · 2017 · 1.1K citations · Full text

Life Sciences, Microbiology, Molecular Medicine +17

Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity

Robert H. Mills, Parambir S. Dulai, Yoshiki Vázquez‐Baeza et al. · Nature Microbiology · 2022 · 385 citations · Full text

Life Sciences, Immunology, Microbiology +14

The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium

Parambir S. Dulai, Siddharth Singh, Xiaoqian Jiang et al. · The American Journal of Gastroenterology · 2016 · 323 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses

Brigid S. Boland, Zhaoren He, Matthew Tsai et al. · Science Immunology · 2020 · 281 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

Neeraj Narula, Farhad Peerani, Joseph Meserve et al. · The American Journal of Gastroenterology · 2018 · 175 citations

Medicine, Internal Medicine, Pharmacotherapy +15

1–5 of 112